Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology
about
Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowthSynovial sarcoma: recent discoveries as a roadmap to new avenues for therapyBiclustering of gene expression data by Non-smooth Non-negative Matrix Factorization.Proteomics of breast cancer: principles and potential clinical applications.EGFR-dependent and independent activation of Akt/mTOR cascade in bone and soft tissue tumors.The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique.Diagnosis and management of synovial sarcoma.Synovial sarcoma: from genetics to genetic-based animal modelingEmerging therapeutic targets for synovial sarcoma.Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.Datamining approach for automation of diagnosis of breast cancer in immunohistochemically stained tissue microarray images.Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stressX-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma.Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assaysValidation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma.Molecular profiling of childhood cancer: Biomarkers and novel therapiesSall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicinThe role of microarray technologies in the study of soft tissue tumours.Diffuse high intensity PD-L1 staining in thymic epithelial tumors.Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics.Diagnostic and prognostic sarcoma signatures.Mathematical algorithm for discovering states of expression from direct genetic comparison by microarraysGene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.The tumor suppressor protein p150(Sal2) in carcinogenesis.Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomasSynovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.Interplay between steroid receptors and neoplastic progression in sarcoma tumors.Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma.Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.Developmental SALL2 transcription factor: a new player in cancer.Aberration of epidermal growth factor receptor expression in bone and soft-tissue tumors: protein overexpression, gene amplification and activation of downstream molecules.Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma.Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.Pitfalls in immunohistochemical assessment of EGFR expression in soft tissue sarcomas.Expression of insulin-like growth factor 2 in mesenchymal neoplasms.Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma.Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
P2860
Q24314686-C2B5ACCA-C5FA-4F91-94CD-2EE1C1A377A2Q28087134-35A45CAA-82CD-48D4-8C31-2E23B762F263Q31033067-7A9E486C-3ADC-4DA8-B2A4-E304E10E0A64Q33245053-9805F7CC-0820-4948-AAB8-AB5AEE7543DDQ33273472-1CA46379-FA2E-42A1-858A-EB9DB638CE1DQ33425217-09315402-5F7F-4D8F-89D6-501630A8733AQ34377983-E4341F44-927B-43A6-8509-E8D30AB02FD7Q34561975-11791EC8-0EB0-433D-9812-C911009CF502Q34593303-5DFCB94A-0016-47AD-960D-6AB72B9EA947Q34660607-87B1F89C-DE07-4A86-BF71-44A407E5B120Q34769647-824AE9F9-7332-4301-BC99-DE17BB723D3AQ34982979-92F3E1FF-2977-44E4-B9E3-916E4C21FCACQ34989369-DEC2D077-9E83-4334-BC02-E241ABE47D18Q35078238-6937BED7-715E-4774-8052-9F382849CE03Q35631966-A9C9BB01-CC83-42E3-97D2-C7D0BEEE8FCDQ36194645-869A7C26-C68A-43FE-B35D-9F72314AA5AEQ36250783-147D3FB7-C955-465E-9F3E-27C8B6D31DEAQ36293819-D400F7A2-C293-4A13-8D8F-3DE4B511C2AEQ36344271-D4C7463D-3E99-4687-B5C0-CBC60E6D29CFQ36483074-EA9E5698-32FA-44AA-BF71-7447DC93BA94Q36973076-5193B24E-A51E-414A-9E19-AB49C72BB4C7Q37335373-8F22E1FB-4462-4ABE-BE33-2BBB4AC79597Q37346294-374E08FC-E29B-455E-8852-11E4CF4A001AQ37468623-7CC4D874-C4D8-4174-9BD6-09A64C6DB855Q38327272-B9006AB9-7FF3-40EF-B379-5242648011C5Q38444611-59150B1B-A181-4112-8810-B1F797EAFF22Q39042581-373D1024-01C2-4AC1-94CD-72953E865218Q39233440-F8FABB2D-D168-4149-B682-8295C78A3C80Q39596152-1DEE1B7B-6655-48C4-9FF5-E71E403656F0Q39624408-BC7C4B4F-B066-41E9-8EEB-631FEE587607Q39929331-705CA674-4755-4FA1-9542-E897AC8AFB80Q40232826-24BEE3DE-142A-486A-BB10-A96868230E32Q40535662-D56D3850-EEFB-43AE-8C7F-24BCDDF8EF40Q41034343-53ACFA63-2A0A-4779-A58C-D04E32CA5641Q42415336-FEB15ABA-E754-44B9-BA99-741E20146FD2Q42835389-2726CBDA-3011-40F9-9A7F-E0B51CB23E17Q43887658-2C305443-EB98-4BDF-9163-8FCB61BEFBEBQ46385316-9BD57C13-AA6D-401E-8103-1102E2CB7B09Q46973585-D1AB0D5D-6945-4171-A022-5505C369EC62Q47114901-0D54AFD9-A085-4466-AA14-2C96569BC79B
P2860
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tissue microarray validation o ...... to tumors of similar histology
@ast
Tissue microarray validation o ...... to tumors of similar histology
@en
Tissue microarray validation o ...... to tumors of similar histology
@nl
type
label
Tissue microarray validation o ...... to tumors of similar histology
@ast
Tissue microarray validation o ...... to tumors of similar histology
@en
Tissue microarray validation o ...... to tumors of similar histology
@nl
prefLabel
Tissue microarray validation o ...... to tumors of similar histology
@ast
Tissue microarray validation o ...... to tumors of similar histology
@en
Tissue microarray validation o ...... to tumors of similar histology
@nl
P2093
P2860
P50
P1476
Tissue microarray validation o ...... to tumors of similar histology
@en
P2093
C Blake Gilks
Chih Long Liu
Forrest D Hsu
John X O'Connell
Poul H B Sorensen
Robert B West
Sabine Linn
Torsten O Nielsen
P2860
P304
P356
10.1016/S0002-9440(10)63502-X
P407
P577
2003-10-01T00:00:00Z